BW-41 (Argo Biopharma)

N/A

Report date: 2026/01/16 09:53:06
NME

Base Information

Drug NameBW-41 (Argo Biopharma)
Drug Alias NameBW-41BW41BW-41 (Shanghai Argo Biopharmaceutical)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRare Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Argo Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Argo Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRare Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A